Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−5.48 SEK
24.98 M SEK
571.33 M SEK
28.70 M
About BOULE DIAGNOSTICS AB
Sector
Industry
CEO
Torben Nielsen
Website
Headquarters
Spanga
Founded
1996
ISIN
SE0011231158
FIGI
BBG001R1FYT3
Boule Diagnostics AB engages in the development, manufacture, sale and marketing of instruments and consumable products for blood diagnostics. It offers automated blood cell counting systems for both the global human and veterinary market. The company was founded in 1992 and is headquartered in Spanga, Sweden.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BOUL is 9.00 SEK — it has increased by 1.35% in the past 24 hours. Watch BOULE DIAGNOSTICS AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange BOULE DIAGNOSTICS AB stocks are traded under the ticker BOUL.
BOUL stock has risen by 3.21% compared to the previous week, the month change is a 33.53% rise, over the last year BOULE DIAGNOSTICS AB has showed a −11.76% decrease.
We've gathered analysts' opinions on BOULE DIAGNOSTICS AB future price: according to them, BOUL price has a max estimate of 9.50 SEK and a min estimate of 9.50 SEK. Watch BOUL chart and read a more detailed BOULE DIAGNOSTICS AB stock forecast: see what analysts think of BOULE DIAGNOSTICS AB and suggest that you do with its stocks.
BOUL reached its all-time high on Aug 27, 2018 with the price of 77.10 SEK, and its all-time low was 5.32 SEK and was reached on Dec 2, 2011. View more price dynamics on BOUL chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BOUL stock is 10.80% volatile and has beta coefficient of 0.04. Track BOULE DIAGNOSTICS AB stock price on the chart and check out the list of the most volatile stocks — is BOULE DIAGNOSTICS AB there?
Today BOULE DIAGNOSTICS AB has the market capitalization of 349.50 M, it has decreased by −4.64% over the last week.
Yes, you can track BOULE DIAGNOSTICS AB financials in yearly and quarterly reports right on TradingView.
BOULE DIAGNOSTICS AB is going to release the next earnings report on Feb 11, 2025. Keep track of upcoming events with our Earnings Calendar.
BOUL earnings for the last quarter are 1.60 SEK per share, whereas the estimation was 0.18 SEK resulting in a 780.58% surprise. The estimated earnings for the next quarter are 0.27 SEK per share. See more details about BOULE DIAGNOSTICS AB earnings.
BOULE DIAGNOSTICS AB revenue for the last quarter amounts to 130.20 M SEK, despite the estimated figure of 131.46 M SEK. In the next quarter, revenue is expected to reach 143.35 M SEK.
BOUL net income for the last quarter is −229.20 M SEK, while the quarter before that showed −1.60 M SEK of net income which accounts for −14.22 K% change. Track more BOULE DIAGNOSTICS AB financial stats to get the full picture.
BOULE DIAGNOSTICS AB dividend yield was 0.00% in 2023, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BOULE DIAGNOSTICS AB EBITDA is −192.80 M SEK, and current EBITDA margin is 11.88%. See more stats in BOULE DIAGNOSTICS AB financial statements.
Like other stocks, BOUL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BOULE DIAGNOSTICS AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BOULE DIAGNOSTICS AB technincal analysis shows the strong buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BOULE DIAGNOSTICS AB stock shows the sell signal. See more of BOULE DIAGNOSTICS AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.